In preparation for the upcoming rescan of evidence for this
coverage guidance, a draft scope statement has been posted for comment from
7/20/2016 to 8 a.m. on 7/27/2016. See our public comment page for
To reflect the updated scope, the name of this coverage guidance will be changed to, "Low Back Pain: Pharmacologic and Herbal Therapies."